The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Clinical trial NCT03505164 · COMPLETED
Trial details
- NCT number
- NCT03505164
- Sponsor
- Rush University Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-17
- Primary completion
- 2020-07-06
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.